SHNXY (Shandong Xinhua Pharmaceutical Co) ROCE %: 7.81% (As of Mar. 2026)


SHNXY Shandong Xinhua Pharmaceutical Co Ltd SHNXY
75 GF Score
Price $18.19
GF Value $21.89
! 5 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co ROCE %?

Shandong Xinhua Pharmaceutical Co SHNXY 75 ROCE % is 7.81% as of Mar. 2026. GuruFocus rates SHNXY with a GF Score™ of 75/100 and a GF Value™ of $21.89. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shandong Xinhua Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.81%.

Shandong Xinhua Pharmaceutical Co  (OTCPK:SHNXY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shandong Xinhua Pharmaceutical Co ROCE % Related Terms

Shandong Xinhua Pharmaceutical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shandong Xinhua Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co ROCE % Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.07 10.04 10.41 9.45 6.48

Shandong Xinhua Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.05 8.71 3.28 4.29 7.81
SHNXY
75GF Score
Shandong Xinhua Pharmaceutical Co Ltd SHNXY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Xinhua Pharmaceutical Co ROCE % Calculation

Shandong Xinhua Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=56.984/( ( (1238.837 - 383.976) + (1304.194 - 399.137) )/ 2 )
=56.984/( (854.861+905.057)/ 2 )
=56.984/879.959
=6.48 %

Shandong Xinhua Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=73.756/( ( (1304.194 - 399.137) + (1315.844 - 333.246) )/ 2 )
=73.756/( ( 905.057 + 982.598 )/ 2 )
=73.756/943.8275
=7.81 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.81% mean?
Shandong Xinhua Pharmaceutical Co (SHNXY) has a ROCE % of 7.81% as of Mar. 2026.
Is Shandong Xinhua Pharmaceutical Co's ROCE % too high?
Shandong Xinhua Pharmaceutical Co's current ROCE % is 7.81%. The Drug Manufacturers industry median ROCE % is 7.03. Shandong Xinhua Pharmaceutical Co's value of 7.81% is 11.1% above this industry median. Overall, Shandong Xinhua Pharmaceutical Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Xinhua Pharmaceutical Co's ROCE % compare to ZTS and UTHR?
Shandong Xinhua Pharmaceutical Co's ROCE % of 7.81% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Shandong Xinhua Pharmaceutical Co's value of 7.81% is 11.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Xinhua Pharmaceutical Co's current ROCE % of 7.81% is 11.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Xinhua Pharmaceutical Co's current ROCE % is 7.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Xinhua Pharmaceutical Co stock overvalued right now?
Shandong Xinhua Pharmaceutical Co (SHNXY) has a current ROCE % of 7.81%. The stock's GF Value™ is $21.89, compared to a current price of $18.19 — trading 16.9% below its estimated fair value. The current ROCE % is 7.81% and 11.1% above the Drug Manufacturers industry median of 7.03. Shandong Xinhua Pharmaceutical Co's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shandong Xinhua Pharmaceutical Co (SHNXY), the current ROCE % is 7.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Xinhua Pharmaceutical Co (SHNXY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of $18.19 is trading 16.9% below its estimated GF Value™ of $21.89.

Key valuation signals for SHNXY:

  • ROCE %: 7.81%
  • GF Value™: $21.89 vs. price of $18.19 (16.9% below fair value)
  • GF Score™: 75/100 with 5 warning signs
  • Industry Position: 11.1% above the Drug Manufacturers median

No single metric tells the full story. See the SHNXY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Xinhua Pharmaceutical Co Business Description

Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
75GF Score

Get the complete analysis for SHNXY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.19
Price
$21.89
GF Value